Caribou Biosciences
CRBU
140 hedge funds and large institutions have $87.6M invested in Caribou Biosciences in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 43 reducing their positions, and 36 closing their positions.
5% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 43
7% less funds holding
Funds holding: 151 → 140 (-11)
15.05% less ownership
Funds ownership: 73.91% → 58.86% (-15%)
25% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 36
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less call options, than puts
Call options by funds: $54K | Put options by funds: $163K
74% less capital invested
Capital invested by funds: $343M → $87.6M (-$255M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$9.73M |
| 2 |
Renaissance Technologies
New York
|
+$4.74M |
| 3 |
Two Sigma Advisers
New York
|
+$3.16M |
| 4 |
Two Sigma Investments
New York
|
+$2.84M |
| 5 |
Jane Street
New York
|
+$1.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$29.7M |
| 2 |
State Street
Boston,
Massachusetts
|
-$15.1M |
| 3 |
Alkeon Capital Management
New York
|
-$14.1M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$11.2M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.67M |
CRBU Hedge Fund Activity: Q2 2024 in Review
140 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q2 2024, worth a combined $87.6M — down 74% from $343M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of CRBU and 27 opened new positions — a net loss of 9 holders — while 43 trimmed existing stakes and 41 added.
The largest buyer was Bank of America, adding an estimated $9.73M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $29.7M sold.
- 140 institutional investors held Caribou Biosciences (CRBU) as of Q2 2024, down from 151 in Q1 2024.
- Funds reported $87.6M of Caribou Biosciences stock for Q2 2024, down 74% quarter-over-quarter.
- 27 funds opened new Caribou Biosciences positions in Q2 2024 and 36 closed out, a net change of -9 holders.
- The largest Caribou Biosciences buyer in Q2 2024 was Bank of America, an estimated $9.73M added.
- The largest Caribou Biosciences seller in Q2 2024 was Avidity Partners Management, an estimated $29.7M sold.
Based on aggregated 13F filings for Q2 2024.